Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.
Saba Capital Management, its general partner, and Boaz R. Weinstein report beneficial ownership of 22,595,026 common shares of BlackRock ESG Capital Allocation Term Trust, equal to 22.72% of the fund’s outstanding stock. The percentage is based on 99,468,307 shares outstanding as of 12/31/25. The group states it has shared voting and dispositive power over all reported shares, held through funds and accounts it advises. Approximately $335,884,529 was paid to acquire these shares, funded by investor subscriptions, capital appreciation, and ordinary-course margin borrowings. All recent trades from 2/27/26 to 3/11/26 were executed in the open market, and the funds and accounts advised by Saba Capital are entitled to dividends and sale proceeds. This Amendment No. 30 updates Items 3, 5, and 7 of the prior Schedule 13D.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. It sold 26,597 shares on March 9, 2026 at $14.47 per share and 47,091 shares on March 10, 2026 at $14.75 per share. After these transactions, Saba Capital indirectly held 22,649,421 ECAT shares.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open-market sales of the trust’s common stock. The transactions totaled 147,371 shares sold across two days.
Saba sold 126,171 common shares on March 5, 2026 at a price of $14.79 per share, followed by 21,200 shares on March 6, 2026 at $14.58 per share. After these sales, Saba indirectly held 22,723,109 common shares.
BlackRock ESG Capital Allocation Term Trust (ECAT) delivers its certified shareholder report for the fiscal period ended 12/31/2025, disclosing distribution composition, portfolio positioning, performance and risks.
ECAT reports total cumulative distributions per common share of $3.537140 for the fiscal period, broken down as $0.219986 net income, $0.024356 long-term capital gains and $3.292798 return of capital. The Board set a monthly fixed amount of $0.278540 per common share; on 1/2/2026 the monthly distribution was decreased to $0.277010 per share. Market close price was $15.38 with NAV $16.17 as of 12/31/2025, and the report shows a one‑year NAV return of 14.33% and since‑inception NAV return of 8.54%. The report also explains use of leverage, option over‑writing and derivatives and lists portfolio weights (equities ~79%, fixed income ~32%) and top holdings.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported open-market sales of the trust’s common stock. It sold 78,578 shares at an average price of $15.01 on March 4, 2026 and 174,550 shares at $14.92 on March 3, 2026, for total reported sales of 253,128 shares. After the most recent transaction, it reported owning 22,870,480 shares indirectly.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust, reported an indirect open-market sale of 244,943 shares of common stock at $15.15 per share. Following this transaction, it indirectly owned 23,123,608 shares of the trust’s common stock.
Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust, reported open-market sales of the trust’s common stock. The firm sold 79,819 shares at $15.16 on February 27, 2026 and 126,687 shares at $15.21 on February 26, 2026, for total reported sales of 206,506 shares. After these indirect transactions, Saba Capital reported holding 23,368,551 shares of common stock.
Saba Capital Management and affiliates filed Amendment No. 29 to their Schedule 13D on BlackRock ESG Capital Allocation Term Trust, updating ownership and board nomination plans. They report beneficial ownership of 23,575,057 common shares, representing 23.73% of the class, based on 99,345,793 shares outstanding as of June 30, 2025.
The filing notes that approximately $350,453,100 was paid to acquire these shares using investor subscription proceeds, capital appreciation and ordinary-course margin borrowings. Saba Capital Master Fund, Ltd. withdrew a prior nominee and now intends to nominate Lawrence Epstein as a Class I director and Wayne Threatt and Lihong Wang as Class III holdover seat nominees for the 2026 annual meeting, each under nomination agreements with Saba Capital.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust, reported two open-market sales of the trust’s common stock. It sold 34,797 shares on February 24, 2026 at an average price of $15.09 per share and 59,356 shares on February 25, 2026 at an average price of $15.27 per share.
After these transactions, Saba Capital indirectly held 23,575,057 shares of common stock, reflecting a net sale of 94,153 shares across the two days.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of fund common stock. On February 19 and 20, 2026, it sold a total of 75,148 shares at prices of $15.03 and $15.07 per share. Following the latest transaction, it indirectly owned 23,669,210 shares of ECAT common stock.